CN1982456B - China amphioxus peptidoglycan recognition protein B.b.PGRP, its production and use - Google Patents
China amphioxus peptidoglycan recognition protein B.b.PGRP, its production and use Download PDFInfo
- Publication number
- CN1982456B CN1982456B CN2006100353102A CN200610035310A CN1982456B CN 1982456 B CN1982456 B CN 1982456B CN 2006100353102 A CN2006100353102 A CN 2006100353102A CN 200610035310 A CN200610035310 A CN 200610035310A CN 1982456 B CN1982456 B CN 1982456B
- Authority
- CN
- China
- Prior art keywords
- pgrp
- gly
- ser
- protein
- lancelet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 101000731015 Homo sapiens Peptidoglycan recognition protein 1 Proteins 0.000 title claims abstract description 34
- 102100032393 Peptidoglycan recognition protein 1 Human genes 0.000 title claims abstract description 34
- 102000052544 Peptidoglycan recognition protein Human genes 0.000 title claims abstract description 8
- 108010009051 Peptidoglycan recognition protein Proteins 0.000 title claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 6
- 241000251522 Cephalochordata Species 0.000 title abstract 3
- 241000894006 Bacteria Species 0.000 claims abstract description 17
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 108010013639 Peptidoglycan Proteins 0.000 claims abstract description 16
- 230000001079 digestive effect Effects 0.000 claims abstract description 8
- 101150108116 PGLYRP1 gene Proteins 0.000 claims description 23
- 241000251538 Branchiostoma lanceolatum Species 0.000 claims description 22
- 230000004927 fusion Effects 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 239000006228 supernatant Substances 0.000 claims description 11
- 239000013604 expression vector Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 5
- 108010042653 IgA receptor Proteins 0.000 claims description 4
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 230000008521 reorganization Effects 0.000 claims description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 3
- 229920002684 Sepharose Polymers 0.000 claims description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 3
- 238000003259 recombinant expression Methods 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 238000002525 ultrasonication Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 13
- 239000002299 complementary DNA Substances 0.000 abstract description 9
- 208000035473 Communicable disease Diseases 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 238000012163 sequencing technique Methods 0.000 abstract description 2
- 235000019750 Crude protein Nutrition 0.000 abstract 1
- 101150002682 PGRP gene Proteins 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000009089 cytolysis Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 150000001413 amino acids Chemical group 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 241000012665 Branchiostoma belcheri tsingtauense Species 0.000 description 4
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000013613 expression plasmid Substances 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 108010077805 Bacterial Proteins Proteins 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
- 235000003969 glutathione Nutrition 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 101001071697 Cavia porcellus Glutathione S-transferase B Proteins 0.000 description 2
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 102000004195 Isomerases Human genes 0.000 description 2
- 108090000769 Isomerases Proteins 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 101001026113 Rattus norvegicus Glutathione S-transferase alpha-1 Proteins 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 102220369447 c.1352G>A Human genes 0.000 description 2
- 238000010523 cascade reaction Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 230000002070 germicidal effect Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 102220023257 rs387907546 Human genes 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 241000251534 Branchiostoma Species 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 241000256113 Culicidae Species 0.000 description 1
- 101100519811 Drosophila melanogaster PGRP-LC gene Proteins 0.000 description 1
- 101100519813 Drosophila melanogaster PGRP-LE gene Proteins 0.000 description 1
- 101100190227 Drosophila melanogaster PGRP-SA gene Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 101001125026 Homo sapiens Nucleotide-binding oligomerization domain-containing protein 2 Proteins 0.000 description 1
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 1
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101000731014 Mus musculus Peptidoglycan recognition protein 1 Proteins 0.000 description 1
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 1
- 102100030397 N-acetylmuramoyl-L-alanine amidase Human genes 0.000 description 1
- 108010020856 N-terminal nucleophile hydrolase Proteins 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 102100029441 Nucleotide-binding oligomerization domain-containing protein 2 Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 102100024333 Toll-like receptor 2 Human genes 0.000 description 1
- 102100039360 Toll-like receptor 4 Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 238000000516 activation analysis Methods 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000012177 large-scale sequencing Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108010069727 pro-phenoloxidase Proteins 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Chinese amphioxus peptidoglycan recognition protein B.b.PGRP, its production and use are disclosed. The process is carried out by constructing cDNA library, large-scaled sequencing, and separating out B.b.PGRP gene from digestive tube of Chinese amphioxus. The crude protein of first check can combine biological macromolecular peptidoglycan specifically and has lysis function for expression strain. It can be used as natural bacterium-inhibiting active substance and to prepare medicine for treating infectious diseases.
Description
Technical field
The present invention relates to Chinese lancelet peptidoglycan recognition protein (B.b.pgrp) gene and encoded protein B.b.PGRP thereof,, and the application of this albumen in preparation treatment infectious disease medicament.。
Background technology
China lancelet (Branchiostoma belcheri tsingtauense) is the good material that the research vertebrates grows as the primitive chordate-cephalochordate that is in the turnover status on the spore status all the time.In recent years, the research of the immunity of lancelet caused widely paid attention to, found many significant immunogenes therein.
Peptidoglycan (peptidoglycan PGN) is one of the main component of the cell walls of nearly all bacterium, especially be rich in gram-positive microorganism, peptidoglycan recognition protein (peptidoglycan recognition protein PGRP) thus be exactly to be responsible for that exclusive molecule plays immunization on this microorganism wall of identification.First is found and is the albumen of the about 19Kda in silkworm that finds of people such as Yoshida in 1996 by the peptidoglycan recognition protein named.This PGRP is found to be exclusive pro-phenoloxidase cascade reaction in the activation insect.Then insects such as moth, fruit bat, mosquitos, and also be found in succession in the animals such as the mouse in the Mammals, rat, people, ox, pig, camel and name.This proteinoid all has the structural domain of identical peptidoglycan identification, by phylogenetic homology relatively, illustrates that this proteinoid guards on evolving.
People such as Choe KM find, fruit bat extracellular protein PGRP-SA participates in the identification gram-positive microorganism, and the proteolytic enzyme in the activation Toll path, this enzyme liberating Toll acceptor spaetzle, thus cascade reaction caused, start transcription factor Dorsal and Dif, (this is with coming from mammiferous NF-κ B), transcribe out a series of antibacterial peptides,, thereby play germicidal action as Drosomysin etc.Transmembrane protein PGRP-LC of fruit bat and PGRP-LE have but participated in an other path, " Imd " path, the bacillus in their identification Gram-negative bacterias and the gram-positive microorganism.TNF path in the similar mammal of this path causes the member Relish in the Rel family, transcribes out antibacterial peptides such as Dipterincin.In addition, this molecule is also inferred the effect that Gram-negative bacteria is engulfed in participation.PGRP except these identification receptor effects, another kind of PGRP is found to have the Ntn hydrolase effect by people such as Steiner H, the PGRP-SC1B of fruit bat, have from the enzymatic activity that cuts between L-acetylmurami and the L-L-Ala, be proved and reduced the immune prototype effect of PGN, thereby played street cleaner's effect in the extracellular.
In Mammals, except S and L, also have two kinds of PGRP, be exactly PGRP-I α and PGRP-I β.Mouse PGRP-S suppresses the growth of gram-positive microorganism under the cell cultures state.High expression level amount is at marrow, and plays germicidal action in the particle in many types of white corpuscle and neutrophilic granulocyte.Mammiferous PGRP-L is considered to the same with the enzyme PGRP of fruit bat mainly at liver expression, has enzymic activity.PGRP-I α and PGRP-I β mainly express in oesophagus, be proved to be positioned at TLR2, TLR4, and the upstream of paths such as NOD1 (nucleotide-binding oligomerization domain) and NOD2.
By the sequence homology analysis, find that the character that this proteinoid has a similar N,O-Diacetylmuramidase promptly has the enzyme active sites of degraded peptidoglycan, prompting plays an important role in the external cause of disease of antagonism, become the antibacterial natural radioactivity albumen of potential, and have the exploitation value of the antibacterials that become efficient natural.Has the wide development prospect in every profession and trades such as kind of an aquaculture, medical and health.
Summary of the invention
The object of the present invention is to provide a kind of new natural antibacterial protein B .b.PGRP and this proteic gene B.b.pgrp of coding.
Another object of the present invention is to provide this proteic production method.
The 3rd purpose of the present invention is to provide the application of this albumen in preparation treatment infectious disease medicament.
The present invention therefrom separates the Chinese lancelet peptidoglycan identification protein gene B.b.pgrp that obtains among the total RNA of state lancelet by the structure in cDNA library and the method for large scale sequencing, its dna sequence dna as in the sequence table<400〉1 sequences shown in.
The protein B .b.PGRP of genes encoding of the present invention, its aminoacid sequence as in the sequence table<400〉2 sequences shown in; This albumen iso-electric point is 7.60, and molecular weight is 27,102 dalton.
This albumen can by expression vector pGEX-B.b.pgrp intestinal bacteria with born of the same parents in soluble form express.
Described expression vector pGEX-B.b.pgrp sets up Thiadiazolidine isomerase for merging the companion body, the middle efficient expression vector that inserts the zymoplasm recognition site, this system make B.b.PGRP in intestinal bacteria with soluble formal representation in the born of the same parents.
The selected Qingdao branchiostoma of the present invention (Branchiostoma belcheri tsingtauense) is collected in sand saliva territory, Shandong Province.
The present invention has therefrom obtained the clone of 1 new coding lancelet B.b.PGRP by to the extensive sequencing of library recombinant clone, called after B.b.pgrp (its dna sequence dna as in the sequence table<400〉1 sequences shown in).New 255 amino acid of genes encoding (its aminoacid sequence as in the sequence table<400〉2 sequences shown in), iso-electric point is 7.60, molecular weight is 27,102 dalton, has the lactamase activity site of conservative PGRP.
The present invention is by having designed a pair of primer, and the new gene B.b.pgrp that will encode is cloned on the prokaryotic fusion expression vector pGEX-4T (Amersham company), construction expression plasmid and with its transformed into escherichia coli BL21 (DE3).This expression vector (pGEX-B.b.pgrp) is that molecule merges the companion body with Thiadiazolidine isomerase GST, helps recombinant protein correctly folding, and with soluble formal representation, the C of GST end has gentle chain plot structure, is convenient to utilize the body affinity chromatography to carry out purifying.The C end of GST contains the zymoplasm restriction enzyme site, is beneficial to the monomeric acquisition of foreign protein.467 amino acid of this fusion rotein coding, iso-electric point is 7.2, molecular weight is 51,804 dalton.By to incubation time, induction time, the groping and optimize of conditions such as temperature, B.b.PGRP Expression of Fusion Protein amount is higher, and major part is in solvable state.
The present invention also gropes and has optimized the proteic purification condition of reorganization B.b.PGRP, and the ultrasonic degradation liquid of expression product obtains purer fusion rotein through GST Sepharose 4B affinity chromatography.
Expression plasmid clone method of the present invention:, use CaCl with reference to Sambrook (Sambrook, et al.1989, Molecularcloing.Cold Spring Harbor Labroratory Press.USA) method
2Method with plasmid Transformed E .coli.DH5 α or BL21 (DE3) bacterial strain, transform bacterial strain with the LB culture medium culturing that contains penbritin (100 μ g/mL), extract plasmid with Omega company test kit.
The present invention has proved that tentatively this has the activity of bacteriolyze.Fusion rotein carries out affine hatching by the peptidoglycan with the streptococcus aureus extraction, carry out the Western-blocking detection with the GST protein monoclonal antibody again and be combined in the sedimentary protein-bonded method of insoluble peptidoglycan, proved the biomacromolecule peptidoglycan of this fusion rotein energy specific combination bacterium surface.
Method by the chloroform bacteriolyze has proved that tentatively this fusion rotein has the bacteriolyze activity, and method is according to the bacteriolyze experiment of tradition checking phage lysozyme success at escherichia coli expression.
Description of drawings
Fig. 1 is Chinese lancelet albumen of the present invention and the proteic comparative result of other species PGRP, wherein " * " table
Show identical; ": " expression difference is less; ". " expression obvious difference; Complete difference is represented in the space.
Fig. 2 is the total RNA of lancelet digestive tube.1:DNA marker DL2000 (Takara); 2: total RNA
The double-stranded cDNA electrophoresis result of Fig. 3.1: double-stranded cDNA PCR electrophoresis; 2:DNA marker widerange (Takara).
Fig. 4 is the recombinant expression plasmid pGEX-B.b.pgrp design of graphics of gene B.bpgrp.
Fig. 5 is the protein induced expression of reorganization B.b.PGRP, affinity chromatography electrophorogram.1: lower molecular weight standard protein marker; 2: without inductive pGEX-B.b.pgrp bacterial protein; 3: through IPTG inductive pGEX-B.b.pgrp bacterial protein; 4: induce the ultrasonic supernatant total protein of bacterium; 5: the percolation peak; 6:10mM reduced glutathion elution peak; 7: remove gsh after crossing the G-25 molecular sieve.
Fig. 6 be the peptidoglycan of B.b.PGRP1 in conjunction with activity: 1: albumen Marker; 2:B.b.PGRP1-GST sample contrast on the ultrasonic supernatant of fusion rotein, the GST monoclonal antibody detects; 3: from the B.b.PGRP1-GST fusion rotein that peptidoglycan elutes, the GST monoclonal antibody detects; 4:B.b.PGRP1-GST merge the wash-out supernatant, the GST monoclonal antibody detects: 5: sample contrast on the ultrasonic supernatant of empty carrier GST albumen, the GST monoclonal antibody detects; 6: from the empty carrier GST albumen that peptidoglycan elutes, the GST monoclonal antibody detects; 7: empty carrier GST albumen wash-out supernatant, the GST monoclonal antibody detects.
Fig. 7 is the active GST of the bacteriolyze of B.b.PGRP1: unloaded albumen; GST-PGRP: fusion rotein; BEFORE: before adding 1% (v/v) chloroform; AFTER: add 1% (v/v) chloroform after ten minutes.
Embodiment
Below implement to help those of ordinary skill in the art further to understand the present invention, but do not limit the present invention in any form.
Embodiment 1: the extraction of the total RNA of Chinese lancelet digestive tube and cDNA's is synthetic
The extraction of total RNA and cDNA are synthetic: collect Chinese lancelet digestive tube, adopt Trizol reagent method (Invitrogen company) to extract the total RNA of digestive tube, protein is removed in phenol/chloroform extracting, obtains the total RNA of Chinese lancelet digestive tube, its A
260/ A
280=1.96, detect as seen 18s and 28s two bands clearly through 1% denaturing formaldehyde gel electrophoresis, ratio>1 (see figure 2) shows that total RNA integrity is better, purity is also higher.Get the total RNA of 1ug, with SMARTIII olignuclotide (5 '-AAGCAGTGGTATCAACGCAGAGTGGCCATTATGGCCGGG-3 ') and CDSIII/3 ' PCR primer (5 '-ATTCTAGAGGCCGAGGCGGCCGACATG-d (T)
30N
-1N-3 ') carries out synthetic first chain of reverse transcription, obtain 10 μ l, one chain cDNA product.
Getting 2ulcDNA one chain product, is that primer carries out the synthetic two chain cDNA of LD-PCR with 5 ' PCR Primer (5 '-TTCCACCCAAGCAGTGGTATCAACGCAGAGTGG-3 ') and 3 ' PCR Primer (5 '-GTATCGATGCCCACCCTCTAGAGGCCGAGGCGGCCGACA-3 ').
Embodiment 2: the mensuration and the analysis of Chinese lancelet digestive tube B.b.pgrp gene order
Two chain cDNA are connected to pcDNA3.0 carrier (available from Invitrogen company), transform DH5 α intestinal bacteria (available from Invitrogen company), select the recombinant clone order-checking.Blast homology analysis revealed has obtained the est sequence of coding total length B.b.pgrp gene, and mrna length all is 765bp, and 255 the amino acid whose B.b.PGRP albumen of encoding are 1 new PGRP albumen.
Use the ClustalW analysis software, to the PGRP protein sequence of the different plant species reported relatively, the result as shown in Figure 1.
As can be seen from Figure 1, PGRP is comparatively conservative in different species.
Embodiment 3: the structure of reorganization pGEX-B.b.pgrp expression plasmid
According to the synthetic a pair of primer of two terminal sequences of B.b.pgrp gene, upstream primer contains the BamHI cleavage site, and downstream primer contains Not I cleavage site.
Upstream primer (P1):
5’CGC
GGATCC?CAGCGGTGGCGCAGTGACG?3’
BamHI
Downstream primer (P2):
5′CGT?
GCGGCCGC?GCCAACGTATCGTCCCCAGGA3′
Not?I
With the pcDNA3.0 plasmid (available from Invitrogen company) that contains the B.b.pgrp gene is template, and P1, P2 are the primer PCR amplification, obtains the single band of specific amplified, and the product size is about 750bp.Pcr amplification product is cloned on the prokaryotic fusion expression vector pGEX (available from Aersham company), obtains recombinant expression vector pGEX-B.b.pgrp (its building process as shown in Figure 4).Foreign gene among the expression vector pGEX-B.b.pgrp is identified correct through order-checking.
Embodiment 4: Chinese lancelet B.b.PGRP Expression of Fusion Protein
With pGEX-B.b.pgrp transformed into escherichia coli BL21 (DE3) (available from Invitrogen company).Genetic engineering bacterium ultrasonic degradation supernatant liquor shows that through the SDS-PAGE electrophoretic analysis bacterial strain has tangible specifically expressing product band after inducing, molecular weight conform to theoretical value 52kD with software DNATOOLS6.0 prediction (Fig. 5).
To incubation time, induced concentration, the groping of conditions such as temperature draws.The culture condition of genetic engineering bacterium is: the order bacterium colony is in 50ml ammonia benzyl resistance LB liquid nutrient medium, 37 ℃, the 250rpm overnight incubation, get in the ammonia benzyl resistance LB substratum that overnight culture 10ml is inoculated in 1L, 37 ℃, 250rpm is cultured to OD600=0.6 (the about 4h of enlarged culturing), adds 100mM IPTG and is respectively 0.2mM to final concentration, 18 ℃, centrifugal collection thalline behind the 250rpm inducing culture 16h.Show that through the SDS-PAGE electrophoretic analysis B.b.PGRP Expression of Fusion Protein amount accounts for more than 40% of bacterial protein with this understanding, be in solvable state (Fig. 5).
Embodiment 5: the purifying of China restructuring lancelet B.b.PGRP fusion rotein
With total thalline 50mM Tris.Cl, 100mMNaCl (pH8.0) washing, use an amount of 50mMTris.Cl again, 100mMNaCl (pH8.0) suspends, after the supersound process, cracking supernatant liquor GST Sepharose 4B affinity chromatography purifying, the expression of SDS-PAGE analysis fusioning protein and the result of chromatography.Can draw from SDS-PAGE result: GST-B.b.PGRP can be adsorbed by affinity column, when washing post with the reduced glutathion of 10mM, can wash target protein GST-B.b.PGRP.Collection obtains the elution peak of recombinant protein.
Elutriant is crossed the G25 gel column except that the reduced glutathion in the Deproteinization, obtains the more single albumen of composition (Fig. 5).
The binding peptide glycan activity of embodiment 6:B.b.PGRP recombinant protein
With the ultrasonic supernatant of the expression bacterium that obtains and the insoluble peptidoglycan that from streptococcus aureus, extracts at 50mMTris.Cl, 4 ℃ of gentle rotations 1 hour among the 100mM NaCl (PH8.0), centrifugal 5 minutes of back 8000g, remove supernatant, use 50mM Tris.Cl again, 100mM NaCl (PH8.0) washing four times, remove the albumen of non-specific combination as far as possible, precipitation and supernatant add loading buffer respectively, carry out SDS-polyacrylamide electrophoresis together with sample on the ultrasonic upward white protein, change film, carrying out Western-block with the GST monoclonal antibody analyzes, compared with the control, on peptidoglycan, eluted purpose B.b.PGRP1-GST fusion rotein band, illustrated that this fusion rotein has the activity of binding peptide glycan.
The activation analysis of embodiment 7:B.b.PGRP recombinant protein
Method by the chloroform bacteriolyze has proved that tentatively this fusion rotein just has the bacteriolyze activity at expression strain, and method is according to the bacteriolyze experiment of tradition checking phage lysozyme success at escherichia coli expression.In the fresh bacterium liquid of abduction delivering, add 1% chloroform, make the cell walls cracking of bacterium, the fusion rotein peptidoglycan that discharges and degrade, thus make bacterium liquid become clarification, dilution is surveyed OD for 10 times after ten minutes
600Value.Naked eyes are the difference fairly obvious (Fig. 6) of experimental group and control group (the unloaded albumen of GST) as can be seen.
Sequence table
<110〉Zhongshan University
<120〉Chinese lancelet peptidoglycan recognition protein B.b.PGRP and its production and application
<140>200610035310.2
<141>2006-04-29
<160>2
<210>1
<211>768
<212>DNA
<213〉lancelet (Branchiostoma belcheri tsingtauense)
<220>
<221>peptide
<222>(1)...(765)
<400>1
atg?gag?acg?aaa?gga?cta?gtc?atc?ctt?ttg?tgc?ctg?ctg?cca?tac?gcg 48
Met?Glu?Thr?Lys?Gly?Leu?Val?Ile?Leu?Leu?Cys?Leu?Leu?Pro?Tyr?Ala
1 5 10 15
gct?gcc?cag?cgg?tgg?cgc?agt?gac?ggc?cgc?tgc?ggc?ccg?aac?tac?ccc 96
Ala?Ala?Gln?Arg?Trp?Arg?Ser?Asp?Gly?Arg?Cys?Gly?Pro?Asn?Tyr?Pro
20 25 30
tcc?cct?gac?gcc?aac?ccg?ggc?gag?tgt?aac?ccg?cac?gcc?gtg?gac?cac 144
Ser?Pro?Asp?Ala?Asn?Pro?Gly?Glu?Cys?Asn?Pro?His?Ala?Val?Asp?His
35 40 45
tgc?tgc?tcg?gag?tgg?ggc?tgg?tgt?ggc?cgg?gag?acc?aca?cac?tgt?acc 192
Cys?Cys?Ser?Glu?Trp?Gly?Trp?Cys?Gly?Arg?Glu?Thr?Thr?His?Cys?Thr
50 55 60
tgc?tct?cgc?tgc?gtg?gac?tat?tcc?gcg?ggt?ggt?ggc?tct?tcg?gga?ggc 240
Cys?Ser?Arg?Cys?Val?Asp?Tyr?Ser?Ala?Gly?Gly?Gly?Ser?Ser?Gly?Gly
65 70 75 80
[0085]tcg?aca?gtc?gtc?gtc?agc?agc?tcg?gga?act?tgt?ccc?agg?atc?gtg?tcc 288
Ser?Thr?Val?Val?Val?Ser?Ser?Ser?Gly?Thr?Cys?Pro?Arg?Ile?Val?Ser
[0087] 85 90 95
aag?tcg?gaa?tgg?ggt?tcc?cgg?gcc?acc?aac?tat?aac?gtg?ttt?ctc?agc 336
Lys?Ser?Glu?Trp?Gly?Ser?Arg?Ala?Thr?Asn?Tyr?Asn?Val?Phe?Leu?Ser
100 105 110
ctg?ccg?gtc?cca?aag?gtt?gtg?atc?cac?cac?tcg?gcg?ggc?gcc?acg?tgc 384
Leu?Pro?Val?Pro?Lys?Val?Val?Ile?His?His?Ser?Ala?Gly?Ala?Thr?Cys
[0093] 115 120 125
agt?acc?cag?tcg?tcc?tgt?tct?cta?cag?gtc?agg?aac?atc?cag?aac?tac 432
Ser?Thr?Gln?Ser?Ser?Cys?Ser?Leu?Gln?Val?Arg?Asn?Ile?Gln?Asn?Tyr
130 135 140
cac?atg?gac?ggc?aga?ggc?tac?agc?gac?atc?ggc?tac?aac?ttc?ctg?gtc 480
His?Met?Asp?Gly?Arg?Gly?Tyr?Ser?Asp?Ile?Gly?Tyr?Asn?Phe?Leu?Val
145 150 155 160
ggt?aac?gat?ggc?aac?gtg?tac?gaa?ggg?cgc?ggc?tgg?gac?agg?aga?ggt 528
Gly?Asn?Asp?Gly?Asn?Val?Tyr?Glu?Gly?Arg?Gly?Trp?Asp?Arg?Arg?Gly
165 170 175
gcg?cat?gcg?ctt?aac?gtc?aac?acc?gag?tcc?atc?ggg?atc?tgc?ttc?atg 576
Ala?His?Ala?Leu?Asn?Val?Asn?Thr?Glu?Ser?Ile?Gly?Ile?Cys?Phe?Met
180 185 190
gga?gac?ttc?acc?agt?cag?aag?ccg?acc?gcc?tcc?gcc?atc?gcc?gcc?gcc 624
[0107]Gly?Asp?Phe?Thr?Ser?Gln?Lys?Pro?Thr?Ala?Ser?Ala?Ile?Ala?Ala?Ala
195 200 205
aag?agc?ctc?atc?tca?tgc?ggg?gtg?tcc?ctg?ggc?aag?atc?agg?tcg?ggc 672
Lys?Ser?Leu?Ile?Ser?Cys?Gly?Val?Ser?Leu?Gly?Lys?Ile?Arg?Ser?Gly
210 215 220
tac?tcc?ctg?tac?gga?cat?cgt?gac?gtc?ggc?tcc?aca?gcc?tgc?cct?ggg 720
tyr?Ser?Leu?Tyr?Gly?His?Arg?Asp?Val?Gly?Ser?Thr?Ala?Cys?Pro?Gly
225 230 235 240
aac?ctg?ctc?tat?gat?gac?atc?aag?tcc?tgg?gga?cga?tac?gtt?ggc?tga 768
Asn?Leu?Leu?Tyr?Asp?Asp?Ile?Lys?Ser?Trp?Gly?Arg?Tyr?Val?Gly *
245 250 255
<210>2
<211>255
<212>PRT
<213〉lancelet (Branchiostoma belcheri tsingtauense)
<220>
<221>peptide
<222>(1)...(255)
<400>2
Met?Glu?Thr?Lys?Gly?Leu?Val?Ile?Leu?Leu?Cys?Leu?Leu?Pro?Tyr?Ala
1 5 10 15
Ala?Ala?Gln?Arg?Trp?Arg?Ser?Asp?Gly?Arg?Cys?Gly?Pro?Asn?Tyr?Pro
20 25 30
Ser?Pro?Asp?Ala?Asn?Pro?Gly?Glu?Cys?Asn?Pro?His?Ala?Val?Asp?His
35 40 45
Cys?Cys?Ser?Glu?Trp?Gly?Trp?Cys?Gly?Arg?Glu?Thr?Thr?His?Cys?Thr
50 55 60
Cys?Ser?Arg?Cys?Val?Asp?Tyr?Ser?Ala?Gly?Gly?Gly?Ser?Ser?Gly?Gly
65 70 75 80
Ser?Thr?Val?Val?Val?Ser?Ser?Ser?Gly?Thr?Cys?Pro?Arg?Ile?Val?Ser
85 90 95
Lys?Ser?Glu?Trp?Gly?Ser?Arg?Ala?Thr?Asn?Tyr?Asn?Val?Phe?Leu?Ser
100 105 110
Leu?Pro?Val?Pro?Lys?Val?Val?Ile?His?His?Ser?Ala?Gly?Ala?Thr?Cys
115 120 125
Ser?Thr?Gln?Ser?Ser?Cys?Ser?Leu?Gln?Val?Arg?Asn?Ile?Gln?Asn?Tyr
130 135 140
His?Met?Asp?Gly?Arg?Gly?Tyr?Ser?Asp?Ile?Gly?Tyr?Asn?Phe?Leu?Val
145 150 155 160
Gly?Asn?Asp?Gly?Asn?Val?Tyr?Glu?Gly?Arg?Gly?Trp?Asp?Arg?Arg?Gly
165 170 175
Ala?His?Ala?Leu?Asn?Val?Asn?Thr?Glu?Ser?Ile?Gly?Ile?Cys?Phe?Met
180 185 190
Gly?Asp?Phe?Thr?Ser?Gln?Lys?Pro?Thr?Ala?Ser?Ala?Ile?Ala?Ala?Ala
195 200 205
Lys?Ser?Leu?Ile?Ser?Cys?Gly?Val?Ser?Leu?Gly?Lys?Ile?Arg?Ser?Gly
210 215 220
tyr?Ser?Leu?Tyr?Gly?His?Arg?Asp?Val?Gly?Ser?Thr?Ala?Cys?Pro?Gly
225 230 235 240
Asn?Leu?Leu?Tyr?Asp?Asp?Ile?Lys?Ser?Trp?Gly?Arg?Tyr?Val?Gly
245 250 255
Claims (3)
1. therefrom separate the Chinese lancelet peptidoglycan identification protein gene B.b.pgrp that obtains among the total RNA of the digestive tube of state lancelet, its dna sequence dna is shown in sequence in the sequence table 1.
2. Chinese lancelet peptidoglycan recognition protein B.b.PGRP, its aminoacid sequence is shown in sequence in the sequence table 2.
3. the production method of protein B .b.PGRP, carry out according to the following steps:
(1) the described gene B.b.pgrp of claim 1 is cloned on the coli expression carrier pGEX-4T, obtains recombinant expression vector pGEX-B.b.pgrp;
(2) with pGEX-B.b.pgrp transformed into escherichia coli bacterial strain BL21 (DE3);
(3) e. coli bl21 (DE3) liquid medium within that transforms is added rich LB and cultivate, cultivate that to add concentration after three hours be that the IPTG of 0.2mM induces in 18 ℃ and spends the night for 37 ℃;
(4) purifying of the Chinese lancelet B.b.PGRP fusion rotein of reorganization specifically is with the centrifugal collection thalline of bacterium liquid, carries out ultrasonication, the centrifuging and taking supernatant liquor, and last GST Sepharose 4B affinity column can obtain purer albumen.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100353102A CN1982456B (en) | 2006-04-29 | 2006-04-29 | China amphioxus peptidoglycan recognition protein B.b.PGRP, its production and use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100353102A CN1982456B (en) | 2006-04-29 | 2006-04-29 | China amphioxus peptidoglycan recognition protein B.b.PGRP, its production and use |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1982456A CN1982456A (en) | 2007-06-20 |
CN1982456B true CN1982456B (en) | 2010-07-21 |
Family
ID=38165300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100353102A Expired - Fee Related CN1982456B (en) | 2006-04-29 | 2006-04-29 | China amphioxus peptidoglycan recognition protein B.b.PGRP, its production and use |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1982456B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103484468A (en) * | 2013-09-11 | 2014-01-01 | 华南农业大学 | Diamondback moth peptidoglycan recognition protein, preparation method and application thereof |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8680235B2 (en) * | 2006-09-22 | 2014-03-25 | Stowers Institute For Medical Research | Branchiostoma derived fluorescent proteins |
CN103131686A (en) * | 2011-11-29 | 2013-06-05 | 中国科学院海洋研究所 | Type two peptidoglycan recognition protein and preparation method and application thereof |
CN102925447B (en) * | 2012-11-06 | 2014-04-02 | 中山大学 | peptidoglycan binding protein BjApextrin1 and BjApextrin2, and genes, production method and application thereof |
CN105132431B (en) * | 2015-09-15 | 2019-03-29 | 盐城工学院 | A kind of Cynoglossus semilaevis peptidoglycan recognition protein Cs-PGRP gene coded protein and its application |
CN113583102B (en) * | 2021-08-28 | 2023-09-19 | 青岛农业大学 | Recombinant protein of paralichthys olivaceus peptidoglycan recognition protein, and preparation method and application thereof |
CN116178521B (en) * | 2023-03-21 | 2024-04-09 | 中国海洋大学 | Fish-source peptidoglycan recognition protein mutant, preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1644697A (en) * | 2004-12-24 | 2005-07-27 | 中山大学 | Thioredoxin peroxidase gene of China Qingdao branchiostoma and use thereof |
-
2006
- 2006-04-29 CN CN2006100353102A patent/CN1982456B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1644697A (en) * | 2004-12-24 | 2005-07-27 | 中山大学 | Thioredoxin peroxidase gene of China Qingdao branchiostoma and use thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103484468A (en) * | 2013-09-11 | 2014-01-01 | 华南农业大学 | Diamondback moth peptidoglycan recognition protein, preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1982456A (en) | 2007-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1982456B (en) | China amphioxus peptidoglycan recognition protein B.b.PGRP, its production and use | |
CN101918431B (en) | Cell-permeabilising peptides and polypeptides for microbial cells | |
CN100584860C (en) | A plurality of reconstructing antibiotic peptide and preparation method and application thereof | |
CN101967485A (en) | Human FGF21 mutant gene and method for preparing recombinant human FGF21 protein | |
CN101092618B (en) | Method for preparing enzyme of dissolving staphylococcal bacteria, its derivative, and method for preparing the derivative | |
CN105859863A (en) | Litopenaeus vannamei antimicrobial peptide-CrustinB gene and preparation and application of recombinant protein of gene | |
CN100535115C (en) | Amphioxus galactose lectin AmphiGAL13-gene and its use | |
CN1606565B (en) | Nucleic acids encoding recominant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses | |
CN112480227B (en) | Protein for improving pathogenic bacterium resistance of sturgeon and preparation method and application thereof | |
CN104195157A (en) | High-efficiency recombination expression and purification method of biological active peptide in prokaryotic cells | |
CN110117587A (en) | A kind of staphylolytic enzyme and its store method and application | |
CN106084024A (en) | Litopenaeus vannamei antibacterial peptide CrustinA gene and the preparation and application of recombiant protein thereof | |
CN100516218C (en) | Toxic sequential, its preparation and use | |
CN105132431B (en) | A kind of Cynoglossus semilaevis peptidoglycan recognition protein Cs-PGRP gene coded protein and its application | |
CN101948890A (en) | Production method of chicken interferon alpha and constructed engineering bacteria | |
CN101914546B (en) | Amphioxus saccharide pattern-recognition molecule Bjfcn1 gene and application thereof | |
CN111690636B (en) | Trypsin-like serine protease gene, encoded protein and application | |
CN101003568A (en) | Recombined diphtheria toxin, preparation method, and application | |
CN102604906A (en) | Bombyx mori glutathione-S-transferase BmGSTD4 and genes thereof | |
CN101775400B (en) | Rana chensinensis functional gene Rd-RNase2 sequence, construction method and amino acid sequence and application thereof | |
CN102127168A (en) | Recombinant fusion protein of triggering receptor-1 expressed on myeloid cells (TREM-1) and application thereof | |
CN102021161A (en) | Preparation method for bacteriophage lyase of streptococcus pneumonia | |
CN100352841C (en) | Antibiotic peptide and its coding sequence and uses | |
CN103484442B (en) | Nod factor lytic enzyme, its encoding gene and application | |
CN103937828A (en) | Preparation method of fusion protein of porcine interferon-alpha 1 and thymosin-alpha 1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100721 Termination date: 20160429 |